SCHEMBL240938

SCHEMBL240938

CCCCCCCCCCCCCC(CCCCCCCCCC)N=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.45
GPR84 Q9NQS5 4/20 0.43
FDPS P14324 3/20 0.43
FFAR1 O14842 1/20 0.43
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
THRB P10828 1/20 0.42
DNM1 Q05193 1/20 0.42
MAPT P10636 1/20 0.41
LCK P06239 1/20 0.41
PPARD Q03181 1/20 0.41
ZDHHC20 Q5W0Z9 1/20 0.41
ZDHHC2 Q9UIJ5 1/20 0.41
CA1 P00915 1/20 0.41
OPRM1 P35372 1/20 0.40
ADH1B P00325 1/20 0.40
ADH1C P00326 1/20 0.40
ADH1A P07327 1/20 0.40
ADH4 P08319 1/20 0.40
ADH7 P40394 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7128030 1.00 CA2 (0.45) CA2GPR84FDPSFFAR1LMNA
SCHEMBL14210207 1.00 CA2 (0.45) CA2GPR84FDPSFFAR1LMNA
SCHEMBL240338 1.00 CA2 (0.45) CA2GPR84FDPSFFAR1LMNA
SCHEMBL10386367 1.00 CA2 (0.45) CA2GPR84FDPSFFAR1LMNA
SCHEMBL1629231 1.00 CA2 (0.45) CA2GPR84FDPSFFAR1LMNA
SCHEMBL9410406 1.00 CA2 (0.45) CA2GPR84FDPSFFAR1LMNA
SCHEMBL10048021 1.00 CA2 (0.45) CA2GPR84FDPSFFAR1LMNA
SCHEMBL3281478 1.00 CA2 (0.45) CA2GPR84FDPSFFAR1LMNA
SCHEMBL10799468 1.00 CA2 (0.45) CA2GPR84FDPSFFAR1LMNA
SCHEMBL10795191 1.00 CA2 (0.45) CA2GPR84FDPSFFAR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 644 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024084471-A1 SAFLUFENACIL MICROEMULSION COMPOSITION, METHOD FOR THE PREPARATION THEREOF AND USE OF SAME DVA AGRO GMBH (DE) 2024-04-25 WO claimed
WO-2022223736-A1 TRANSITION METAL OXIDE ADDUCTS FOR REGULATED GENERATION OF REACTIVE OXYGEN SPECIES AURENA LABORATORIES HOLDING AB (SE) 2022-10-27 WO claimed
US-20190099342-A1 COOLING PRODUCT SYMRISE AG (DE) 2019-04-04 US claimed
EP-2770835-B1 SPORICIDAL FORMULATION INCLUDING AMINE OXIDE SURFACTANT AND A MIXTURE OF OXIDANTS KIMBERLY CLARK CO (US) 2017-06-21 EP claimed
US-20150110893-A1 Sporicidal Formulation Including Amine Oxide Surfactant And A Mixture Of Oxidants KIMBERLY-CLARK WORLDWIDE, INC. 2015-04-23 US claimed
EP-2770835-A1 SPORICIDAL FORMULATION INCLUDING AMINE OXIDE SURFACTANT AND A MIXTURE OF OXIDANTS Kimberly-Clark Worldwide, Inc. (US) 2014-09-03 EP claimed
WO-2013059970-A1 SPORICIDAL FORMULATION INCLUDING AMINE OXIDE SURFACTANT AND A MIXTURE OF OXIDANTS KIMBERLY-CLARK WORLDWIDE, INC. (US) 2013-05-02 WO claimed
EP-2136773-A2 COMPOSITIONS CONTAINING AMINE OXIDE SURFACTANTS OR SOIL PENETRATION AGENTS The Procter & Gamble (US) 2009-12-30 EP claimed
US-20090005281-A1 Compositions Containing Amine Oxide Surfactants or Soil Penetration Agents PROCTER & GAMBLE COMPANY, THE 2009-01-01 US claimed
WO-2008114232-A2 COMPOSITIONS CONTAINING AMINE OXIDE SURFACTANTS OR SOIL PENETRATION AGENTS THE PROCTER & GAMBLE COMPANY (US) 2008-09-25 WO claimed
WO-2026087745-A1 AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE BRAIN Biotech AG (DE) 2026-04-30 WO disclosed
EP-4732825-A1 AN ANTIOXIDANT COMPOSITION COMPRISING A CINNAMIC ACID DERIVATIVE BRAIN Biotech AG (DE) 2026-04-29 EP disclosed
US-20260096978-A1 A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS SYMRISE AG (DE) 2026-04-09 US disclosed
EP-4186969-B1 SUPER-CONCENTRATED DILUTABLE POWDER FOR DISHWASHING APPLICATION HENKEL AG & CO KGAA (DE) 2026-04-01 EP disclosed
EP-4025675-B1 A PERFUME OIL MIXTURE SYMRISE AG (DE) 2026-03-18 EP disclosed
US-20010056047-A1 Cleaning of fruit, vegetables, and meats HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA) (DE) 2001-12-27 US disclosed
WO-2001085896-A1 CONCENTRATE FOR DILUTION WITH MAINTENANCE OF OR AN INCREASE IN VISCOSITY HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-11-15 WO disclosed
US-20010031712-A1 Surfactant Combination HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (HENKEL KGAA (DE) 2001-10-18 US disclosed
WO-2001072149-A1 WASHING OF FRUIT AND VEGETABLES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2001-10-04 WO disclosed
WO-2000065020-A1 HAND DISH WASHING DETERGENT WITH MICROCAPSULES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2000-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190099342-A1 COOLING PRODUCT TRPA1, TRPV2, NISCH CA2 737/4885GPR84 4329/4885FDPS 3152/4885
US-20260096978-A1 A METHOD FOR PREVENTING, MITIGATING AND/OR TREATING PTGS2-INDUCED SKIN DISORDERS AND RELATED DYSFUNCTIONS PTGS2, PTGES2, PTGS1 CA2 332/4885GPR84 696/4885FDPS 1905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.